← All organizations

CancerVax Corporation

For profit

Also known as: CancerVax Corp | CancerVax Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 31, 2005

Acquired by Micromet → Amgen on Jan 1, 2003

Timeline

1990s

Jan 1, 1998
CancerVax Corporation— Founded

2000s

Jan 1, 2002
Cell-Matrix— Acquired
Jan 1, 2003
Micromet— Acquired By

2010s

Jan 1, 2012
Amgen— Now

Drugs by trial phase (2 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

canvaxin

Phase 2 (1 own, 0 via acquisition)

melanoma vaccine

Indications

Studied for

Melanoma

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Cell-Matrix

Recent trials (4)

NCT00128583Lead sponsorPhase 2Jul 31, 2005
NCT00128583Study chairPhase 2Jul 31, 2005
NCT00052156Lead sponsorPhase 3Jan 23, 2003
NCT00052130Lead sponsorPhase 3Jan 22, 2003

Details

Founded: Wilmington, DE, US Jan 1, 1998
Last known activity: Jul 31, 2005